Prosecution Insights
Last updated: May 29, 2026

UNIVERSITEIT ANTWERPEN

11 pending office actions • 11 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days

Portfolio Summary

11
Total Pending OAs
7
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

8
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (8)Due ≤ 30 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
9
Medium (82%)
2
Easy (18%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only8 (73%)
§102 only1 (9%)
§112 only2 (18%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
55% of docket
1
Information Tech
9% of docket
1
Communications
9% of docket
1
Semiconductors
9% of docket
2
Mechanical / Eng
18% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HALL, FORREST G 1 59.9% +32.0%
TSUI, YUNG-SHENG M 1 66.0% +6.7%
GETZOW, SCOTT M 1 80.6% +0.2%
GRASER, JENNIFER E 1 76.7% +23.8%
DOYLE, BRANDI M 1 62.8% +11.1%
O DELL, DAVID K 1 57.8% +35.8%
THOMPSON, KYLE ALLMAN 1 85.7% +33.3%
BITAR, NANCY 1 82.8% +8.4%
STOFFA, WYATT A 1 79.9% +22.4%
CHEN, STACY BROWN 1 65.9% +40.1%

Quick Wins (3)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18267589 METHOD FOR MODELLING A NASAL CAVITY BITAR, NANCY 49d overdue
18291554 TOOL FOR CONTINUOUS INSERTION-DEPTH MONITORING FOR IMPLANTABLE LEAD GETZOW, SCOTT M 38d overdue
18267624 TRAFFIC PREDICTION THOMPSON, KYLE ALLMAN 8d overdue

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18705646 AN OVERALL HALL, FORREST G 141d overdue
18548763 APPARATUS FOR GENERATING A FLUIDIZED BED DOYLE, BRANDI M 91d overdue
17761459 HUMAN RESPIRATORY SYNCYTIAL VIRUS STRAIN AND ITS USE CHEN, STACY BROWN 17d overdue
18265897 CHARGED PARTICLE MICROSCOPY MEMS SAMPLE SUPPORT STOFFA, WYATT A 16d overdue
18267624 TRAFFIC PREDICTION THOMPSON, KYLE ALLMAN 8d overdue
18552827 Vaccine Compositions for Trypanosomatids GRASER, JENNIFER E 3d overdue
18276532 QUINAZOLIN-4-ONE AND THIENO[2,3-D]PYRIMIDIN-4-ONE INHIBITORS OF ERBB4 (HER4) FOR USE IN THE TREATMENT OF CANCER O DELL, DAVID K 21d

Top Art Units

Art UnitApps
3732 1
1684 1
3792 1
1645 1
1771 1
1621 1
2125 1
2664 1
2881 1
1672 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18705646 AN OVERALL HALL, FORREST G 3732 §103 Final Rejection 141d overdue Pending Apr 29, 2024
18690996 FEEDING SYSTEM FOR FEEDING POWDER MATERIAL AND SYSTEM FOR CONTINUOUS PRODUCTION OF SOLID DOSAGE FORMS TSUI, YUNG-SHENG M 1684 §102 Non-Final OA 75d Pending Mar 11, 2024
18291554 TOOL FOR CONTINUOUS INSERTION-DEPTH MONITORING FOR IMPLANTABLE LEAD GETZOW, SCOTT M 3792 §103 Non-Final OA 38d overdue Pending Jan 23, 2024
18552827 Vaccine Compositions for Trypanosomatids GRASER, JENNIFER E 1645 §103 Non-Final OA 3d overdue Pending Sep 27, 2023
18548763 APPARATUS FOR GENERATING A FLUIDIZED BED DOYLE, BRANDI M 1771 §103 Non-Final OA 91d overdue Pending Sep 01, 2023
18276532 QUINAZOLIN-4-ONE AND THIENO[2,3-D]PYRIMIDIN-4-ONE INHIBITORS OF ERBB4 (HER4) FOR USE IN THE TREATMENT OF CANCER O DELL, DAVID K 1621 §103 Non-Final OA 21d Pending Aug 09, 2023
18267624 TRAFFIC PREDICTION THOMPSON, KYLE ALLMAN 2125 §103 Non-Final OA 8d overdue Pending Jun 15, 2023
18267589 METHOD FOR MODELLING A NASAL CAVITY BITAR, NANCY 2664 §103 Final Rejection 49d overdue Pending Jun 15, 2023
18265897 CHARGED PARTICLE MICROSCOPY MEMS SAMPLE SUPPORT STOFFA, WYATT A 2881 §103 Final Rejection 16d overdue Pending Jun 07, 2023
17761459 HUMAN RESPIRATORY SYNCYTIAL VIRUS STRAIN AND ITS USE CHEN, STACY BROWN 1672 §112 Final Rejection 17d overdue Pending Mar 17, 2022
17627953 MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER DYSFUNCTION BORGEEST, CHRISTINA M 1675 §112 Non-Final OA 13d Pending Jan 18, 2022

Managing UNIVERSITEIT ANTWERPEN's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month